Vanderbilt-Ingram Cancer Center
Search Clinical Trials
Showing 214 Open Interventional Clinical Trials
Colon, Esophageal, GIST, Gastric/Gastroesophageal, Gastrointestinal, Liver, Pancreatic, Rectal
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
Cervical, Gynecologic, Ovarian, Prostate, Urologic, Uterine
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Miscellaneous
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Esophageal, Gastric/Gastroesophageal
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Germ Cell (Pediatrics), Pediatrics
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Bladder, Colon, Esophageal, Gastric/Gastroesophageal, Head/Neck, Kidney (Renal Cell), Lung, Ovarian, Pancreatic, Urologic
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Leukemia, Myelodysplastic Syndrome
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Pediatrics, Wilms / Other Kidney (Pediatrics)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Miscellaneous
A Study of PHST001 in Advanced Solid Tumors
Pediatric Lymphoma, Pediatrics
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Breast, Cervical, Gastrointestinal, Gynecologic, Head/Neck, Lung, Urologic
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Esophageal, Gastric/Gastroesophageal, Gastrointestinal
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Hematologic, Myelodysplastic Syndrome
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
Germ Cell (Pediatrics), Gynecologic, Ovarian
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Multiple Myeloma
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Colon, Lung, Miscellaneous, Pancreatic
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Dermatologic, Head/Neck, Supportive Care
Cemiplimab and Quad Shot Radiation for Cutaneous Squamous Cell Carcinoma in the Head and Neck
Neuro-Oncology, Pediatrics
Digoxin Medulloblastoma Study
Neuro-Oncology, Neuroblastoma (Pediatrics), Pediatric Solid Tumors, Pediatrics, Sarcoma
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Breast
ETHAN - ET for Male BC
Neuroblastoma (Pediatrics), Pediatric Solid Tumors
Expanded Access Protocol Using 131I-MIBG
Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome
MAGIC Ruxolitinib for aGVHD
Pediatric Solid Tumors, Sarcoma
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Adrenocortical, Bladder, Breast, Cervical, Colon, Dermatologic, Esophageal, GIST, Gastric/Gastroesophageal, Gastrointestinal, Gynecologic, Head/Neck, Kidney (Renal Cell), Liver, Lung, Melanoma, Miscellaneous, Ovarian, Pancreatic, Prostate, Rectal, Sarcoma, Thyroid, Urologic, Uterine
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Neuro-Oncology
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Breast, Head/Neck, Lung, Non Small Cell, Ovarian, Uterine
SMP-3124LP in Adults With Advanced Solid Tumors
Bladder, Kidney (Renal Cell), Prostate, Urologic
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Colon, Esophageal, Gastric/Gastroesophageal, Gastrointestinal, Liver, Pancreatic, Rectal
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Breast, Gastrointestinal, Gynecologic, Head/Neck, Lung, Melanoma, Neuro-Oncology, Sarcoma, Urologic
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Neuroendocrine, Pancreatic
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Neuroblastoma (Pediatrics)
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Head/Neck, Neuro-Oncology
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Disclaimer
This summary is based on publicly available information from clinicaltrials.gov and is intended to help patients discuss possible trial options with their oncology care team. ClinicalTrials.gov and related public listings do not independently review or approve the safety and scientific merit of every study.
Participation decisions can be made only after review by the study team and your treating clinician.